These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 23529793)

  • 1. RANKL subcellular trafficking and regulatory mechanisms in osteocytes.
    Honma M; Ikebuchi Y; Kariya Y; Hayashi M; Hayashi N; Aoki S; Suzuki H
    J Bone Miner Res; 2013 Sep; 28(9):1936-49. PubMed ID: 23529793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MLO-Y4 osteocyte-like cells support osteoclast formation and activation.
    Zhao S; Zhang YK; Harris S; Ahuja SS; Bonewald LF
    J Bone Miner Res; 2002 Nov; 17(11):2068-79. PubMed ID: 12412815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory mechanisms of RANKL presentation to osteoclast precursors.
    Honma M; Ikebuchi Y; Kariya Y; Suzuki H
    Curr Osteoporos Rep; 2014 Mar; 12(1):115-20. PubMed ID: 24477414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of membrane- or matrix-associated forms of M-CSF and RANKL/ODF in osteoclastogenesis supported by SaOS-4/3 cells expressing recombinant PTH/PTHrP receptors.
    Itoh K; Udagawa N; Matsuzaki K; Takami M; Amano H; Shinki T; Ueno Y; Takahashi N; Suda T
    J Bone Miner Res; 2000 Sep; 15(9):1766-75. PubMed ID: 10976996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Function of OPG as a traffic regulator for RANKL is crucial for controlled osteoclastogenesis.
    Aoki S; Honma M; Kariya Y; Nakamichi Y; Ninomiya T; Takahashi N; Udagawa N; Suzuki H
    J Bone Miner Res; 2010 Sep; 25(9):1907-21. PubMed ID: 20560139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteocytes produce interferon-β as a negative regulator of osteoclastogenesis.
    Hayashida C; Ito J; Nakayachi M; Okayasu M; Ohyama Y; Hakeda Y; Sato T
    J Biol Chem; 2014 Apr; 289(16):11545-11555. PubMed ID: 24610813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-6 Enhances Osteocyte-Mediated Osteoclastogenesis by Promoting JAK2 and RANKL Activity In Vitro.
    Wu Q; Zhou X; Huang D; Ji Y; Kang F
    Cell Physiol Biochem; 2017; 41(4):1360-1369. PubMed ID: 28278513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trapidil, a platelet-derived growth factor antagonist, inhibits osteoclastogenesis by down-regulating NFATc1 and suppresses bone loss in mice.
    Kim SD; Kim HN; Lee JH; Jin WJ; Hwang SJ; Kim HH; Ha H; Lee ZH
    Biochem Pharmacol; 2013 Sep; 86(6):782-90. PubMed ID: 23928189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptotic osteocytes regulate osteoclast precursor recruitment and differentiation in vitro.
    Al-Dujaili SA; Lau E; Al-Dujaili H; Tsang K; Guenther A; You L
    J Cell Biochem; 2011 Sep; 112(9):2412-23. PubMed ID: 21538477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High mobility group box 1 protein regulates osteoclastogenesis through direct actions on osteocytes and osteoclasts in vitro.
    Davis HM; Valdez S; Gomez L; Malicky P; White FA; Subler MA; Windle JJ; Bidwell JP; Bruzzaniti A; Plotkin LI
    J Cell Biochem; 2019 Oct; 120(10):16741-16749. PubMed ID: 31106449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iron Overload-Induced Osteocyte Apoptosis Stimulates Osteoclast Differentiation Through Increasing Osteocytic RANKL Production In Vitro.
    Yang J; Dong D; Luo X; Zhou J; Shang P; Zhang H
    Calcif Tissue Int; 2020 Nov; 107(5):499-509. PubMed ID: 32995951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 4-1BB ligand and 4-1BB expressed on osteoclast precursors enhance RANKL-induced osteoclastogenesis via bi-directional signaling.
    Yang J; Park OJ; Lee YJ; Jung HM; Woo KM; Choi Y
    Eur J Immunol; 2008 Jun; 38(6):1598-609. PubMed ID: 18421790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclic adenosine monophosphate/protein kinase A mediates parathyroid hormone/parathyroid hormone-related protein receptor regulation of osteoclastogenesis and expression of RANKL and osteoprotegerin mRNAs by marrow stromal cells.
    Kondo H; Guo J; Bringhurst FR
    J Bone Miner Res; 2002 Sep; 17(9):1667-79. PubMed ID: 12211438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unfractionated Heparin Promotes Osteoclast Formation in Vitro by Inhibiting Osteoprotegerin Activity.
    Li B; Lu D; Chen Y; Zhao M; Zuo L
    Int J Mol Sci; 2016 Apr; 17(4):. PubMed ID: 27110777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cortical bone loss caused by glucocorticoid excess requires RANKL production by osteocytes and is associated with reduced OPG expression in mice.
    Piemontese M; Xiong J; Fujiwara Y; Thostenson JD; O'Brien CA
    Am J Physiol Endocrinol Metab; 2016 Sep; 311(3):E587-93. PubMed ID: 27460899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble glucocorticoid-induced tumor necrosis factor receptor stimulates osteoclastogenesis by down-regulation of osteoprotegerin in bone marrow stromal cells.
    Shin HH; Kim SJ; Kang SY; Lee DS; Choi HS
    Bone; 2006 Oct; 39(4):716-23. PubMed ID: 16750437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vps33a mediates RANKL storage in secretory lysosomes in osteoblastic cells.
    Kariya Y; Honma M; Aoki S; Chiba A; Suzuki H
    J Bone Miner Res; 2009 Oct; 24(10):1741-52. PubMed ID: 19419298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of fluoride on osteocyte-driven osteoclastic differentiation.
    Jiang N; Guo F; Xu W; Zhang Z; Jin H; Shi L; Zhang X; Gao J; Xu H
    Toxicology; 2020 Apr; 436():152429. PubMed ID: 32156525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factor beta affects osteoclast differentiation via direct and indirect actions.
    Quinn JM; Itoh K; Udagawa N; Hausler K; Yasuda H; Shima N; Mizuno A; Higashio K; Takahashi N; Suda T; Martin TJ; Gillespie MT
    J Bone Miner Res; 2001 Oct; 16(10):1787-94. PubMed ID: 11585342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lenalidomide regulates osteocytes fate and related osteoclastogenesis via IL-1β/NF-κB/RANKL signaling.
    Qu X; Mei J; Yu Z; Zhai Z; Qiao H; Dai K
    Biochem Biophys Res Commun; 2018 Jun; 501(2):547-555. PubMed ID: 29746861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.